Integrated strategies to optimize sputum smear microscopy: a prospective observational study
- PMID: 20851925
- PMCID: PMC3056227
- DOI: 10.1164/rccm.201008-1207OC
Integrated strategies to optimize sputum smear microscopy: a prospective observational study
Abstract
Rationale: Smear-positive tuberculosis (TB) case detection rates are far below targets in most low-income countries. The standard approach to smear microscopy involves sputum collection over multiple days and examination of sputum smears by light microscopy (LM), an insensitive and time-consuming technique.
Objective: To determine whether two alternative approaches can increase smear-positive case detection by increasing the efficiency (single-specimen microscopy) or sensitivity (light-emitting diode [LED] fluorescence microscopy [FM]) of TB suspect evaluation.
Methods: We enrolled patients with cough of 2 weeks or more admitted to Mulago Hospital in Kampala, Uganda and collected spot and early morning sputum specimens. We compared the diagnostic accuracy of four prespecified strategies based on the number of sputum specimens collected (one specimen versus two specimens) and the type of microscopy (LM versus LED FM) using mycobacterial culture as a reference standard.
Measurements and main results: Two hundred thirty-three of 464 (50%) patients had culture-positive TB. There was no difference in sensitivity between single-specimen and two-specimen strategies when smears were examined with LM (55 vs. 56%; difference, -1%; 95% confidence interval [CI], -5 to +2%) or LED FM (61 vs. 64%; difference, -3%; 95% CI, -7 to +1%). LED FM was more sensitive than LM with both the single-specimen (61 vs. 55%; difference, 6%; 95% CI, 2-10%) and two-specimen strategies (64 vs. 56%; difference, 8%; 95% CI, 3-12%). Findings were similar among the HIV-infected patient subset (n = 321 patients).
Conclusions: In low-income, high TB burden settings, single-specimen microscopy and LED FM, either alone or in combination, could considerably increase identification of smear-positive TB cases.
Figures


Comment in
-
Streamlining the diagnostic journey for patients with tuberculosis: another step forward.Am J Respir Crit Care Med. 2011 Feb 15;183(4):429-30. doi: 10.1164/rccm.201010-1616ED. Am J Respir Crit Care Med. 2011. PMID: 21325082 No abstract available.
References
-
- World Health Organization. Global tuberculosis control: a short update to the 2009 report. Geneva, Switzerland: WHO Press; 2009. WHO/HTM/TB/2009.426.
-
- Stop TB Partnership, World Health Organization. Global plan to stop TB: 2006–2015. Geneva, Switzerland: WHO Press; 2006. WHO/HTM/STB/2006.35.
-
- Stop TB Partnership, World Health Organization. New technologies for tuberculosis control: a framework for their adoption, introduction and implementation. Geneva, Switzerland: WHO Press; 2007. WHO/HTM/STB/2007.40.
-
- Botha E, den Boon S, Lawrence KA, Reuter H, Verver S, Lombard CJ, Dye C, Enarson DA, Beyers N. From suspect to patient: tuberculosis diagnosis and treatment initiation in health facilities in South Africa. Int J Tuberc Lung Dis 2008;12:936–941. - PubMed
-
- Squire SB, Belaye AK, Kashoti A, Salaniponi FM, Mundy CJ, Theobald S, Kemp J. “Lost” smear-positive pulmonary tuberculosis cases: where are they and why did we lose them? Int J Tuberc Lung Dis 2005;9:25–31. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources